文献速递心脏核医学

锝-99m焦磷酸盐单光子发射计算机断层显像视觉分级在接受稳定治疗的转甲状腺素蛋白心脏淀粉样变性患者中的预后价值

Prognostic value of 99mtechnetium-pyrophosphate single-photon emission computed tomography visual grade in patients with transthyretin cardiac amyloidosis on stabilization therapy.
PubMed 文献 · J Nucl Cardiol · 2025-06-13

这项回顾性队列研究纳入344例接受TTR稳定治疗的ATTR-CM患者,评估99mTc-PYP-SPECT视觉分级对预后的价值。中位随访27个月期间76例(22.1%)死亡。校正年龄、NAC分期、NYHA分级、左心室质量指数、左心室射血分数和99mTc-PYP-SPECT视觉分级后,仅NAC分期(HR 4.01,P<.001)和NYHA分级(HR 5.22,P=.011)强烈预测死亡,淀粉样负荷视觉分级无预后价值。

要点

  • 在接受TTR稳定治疗的ATTR-CM患者中,NAC分期和NYHA分级是死亡的强预测因素。
  • 99mTc-PYP-SPECT视觉分级(2级或3级)不是死亡的独立预测因素。
  • 作者支持将99mTc-PYP视觉分级2级和3级合并为单一阳性分级。

核心结论

  • 在接受TTR稳定治疗的ATTR-CM患者中,由NAC分期和NYHA分级反映的器官功能障碍是死亡的强预测因素,而99mTc-PYP-SPECT视觉分级反映的淀粉样负荷不是。
  • 作者支持将99mTc-PYP视觉分级2级和3级修订为单一阳性分级。
  • 未来工作需要评估定量99mTc-PYP-SPECT测定的淀粉样负荷是否在ATTR-CM中提供预后价值。

研究设计与样本

  • 回顾性队列研究,纳入344例接受TTR稳定治疗的ATTR-CM参与者。
  • 99mTc-PYP-SPECT心肌摄取根据心肌摄取与肋骨摄取比较分为0、1、2、3级:无摄取、低于肋骨、等于肋骨、高于肋骨。
  • NAC分期由N末端B型利钠肽原(≤3000 pg/mL)和估算肾小球滤过率(≥45 mL/min/1.73 m2)水平定义。
  • 主要结局为全因死亡,采用Kaplan-Meier生存分析和多变量Cox回归分析。

主要发现

  • 344例参与者中位年龄80岁,88%为男性,98%的99mTc-PYP-SPECT视觉分级摄取为2级或3级。
  • 中位随访27个月期间,76例参与者(22.1%)死亡。
  • 在校正年龄、NAC分期、NYHA分级、左心室质量指数、左心室射血分数和99mTc-PYP-SPECT视觉分级的Cox回归分析中,仅NAC分期(HR 4.01,P<.001)和NYHA分级(HR 5.22,P=.011)强烈预测死亡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of our study was to evaluate the prognostic value of amyloid burden estimated by technetium-pyrophosphate single-photon emission computed tomography (99mTc-PYP-SPECT) visual grade in patients with transthyretin (ATTR) amyloid cardiomyopathy (ATTR-CM) receiving TTR stabilization therapy. METHODS: Our retrospective cohort study included 344 ATTR-CM participants receiving TTR stabilization therapy. 99mTc-PYP-SPECT myocardial uptake was graded as 0, 1, 2, or 3, based on myocardial uptake that was absent, less than, equal to, or greater than rib uptake, respectively. National Amyloidosis Center (NAC) stage was defined by N-terminal pro B-type natriuretic peptide (≤3000 pg/mL) and estimated glomerular filtration rate (≥45 mL/min/1.73 m2) levels. The primary outcome was all-cause mortality. Kaplan-Meier survival and multivariable Cox regression analyses were performed. RESULTS: Of the 344 participants (median age: 80 years), 88% were men and 98% had a 99mTc-PYP-SPECT visual grade uptake of 2 or 3. Seventy-six participants (22.1%) died during follow-up (median: 27 months). In the Cox regression analysis adjusted for age, NAC stage, New York Heart Association (NYHA) class, left ventricular (LV) mass index, LV ejection fraction, and 99mTc-PYP-SPECT visual grade, only NAC stage (hazard ratio [HR]: 4.01, P value <.001) and NYHA class (HR: 5.22, P value = .011) strongly predicted mortality. CONCLUSIONS: In patients with ATTR-CM receiving TTR stabilization therapy, organ dysfunctions evidenced by NAC stage and NYHA class, but not by amyloid burden on 99mTc-PYP-SPECT visual grade, are strong predictors of mortality. Our results support a revision to 99mTc-PYP visual grading 2 and 3 into a single grade (positive). Future work is needed to evaluate whether amyloid burden measured by quantitative 99mTc-PYP-SPECT offers prognostic value in ATTR-CM.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Romero Pabón AJ, Clerc OF, Cuddy SAM, et al. Prognostic value of 99mtechnetium-pyrophosphate single-photon emission computed tomography visual grade in patients with transthyretin cardiac amyloidosis on stabilization therapy. J Nucl Cardiol. 2025. PMID: 40518107. doi:10.1016/j.nuclcard.2025.102275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。